Hansoh Biomedical R&d Company

This study aims to find a safe and effective dose of a new combination drug called HS-20110 for people with advanced colorectal cancer that has spread. It will test the treatment in about 500 adults to see how well their bodies handle it and if it can shrink or control their tumo…

This study is for people with advanced non-squamous non-small cell lung cancer that has worsened after previous treatment. Researchers want to see if a new two-drug combination (HS-20093 plus adebrelimab) works better and is safer than the standard chemotherapy drug docetaxel. Ab…